Interview with Francisco Gonzalez A., Managing Director, Boehringer Ingelheim…
What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile?…
Boehringer Ingelheim Chile
Last updated: 01.06.2015
Address: General del Canto 421 – 6th Floor Providencia, Santiago de Chile
Tel: 5623275010
Web: http://www.boehringer-ingelheim.com/
Company description
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world’s 20 leading pharmaceutical companies. In 2009 it had 142 affiliated companies in 47 countries employing 41,534 employees and with net sales of EUR 12,721 million.
The corporate vision of the company is given by one single phrase: ‘Value through Innovation’. The company was founded in Ingelheim am Rhein (Germany) in 1885, where the corporate headquarters is still located.
The business is divided into the following business areas: Human Pharmaceuticals, Prescription Medicines, Consumer Health Care, Industrial Customer, Biopharmaceuticals, Pharmaceuticals Production, Pharma Chemicals and Animal Health, the largest one being Prescription medicines, where 21% of the net sales is spent in R&D.
Boehringer Ingelheim Chile acts as a distributor of the company’s products in the local market. Supply for the Chilean market is provided by the company’s manufacturing plants in Brazil, Argentina, Colombia and Mexico. Nevertheless, Boehringer Ingelheim conducts several clinical trials in Chile.
Products and services
Respiratory diseases, Cardiometabolic diseases, Oncology, Neurological diseases, Immunology, Infectious diseases
Interviews
Related
LATAM / Chilean Healthcare Reform: “Deep & Comprehensive” but Unable to Calm the Protests?
Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera…
Interview: Fabrice Chouraqui – President Latin America & Canada,…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times…
When you can’t move the mountain: distribution in Chile
Although Chile is a relatively small market, with only 17 million inhabitants, its geography makes it a challenging…
Level playing field: Chile aims for bioequivalence in 2014
Chile is aiming to achieve complete bioequivalence of generics by the end of 2014. Chile’s Public Health…
Interview: Elmer Torres Cortes, General Manager, ASILFA, Chile
Elmer Torres Cortes is General Manager of the Industrial Association of Pharmaceutical Laboratories (ASILFA) that…
Interview: Paula Ithurbisquy, General Manager, Clinica Alemana, Chile
“Clinica Alemana’s objective is to be the most patient-centric clinic and we take that very seriously.…
Interview: Luis Aguilera, General Manager, Deutsche Pharma, Chile
Deutsche Pharma’s general manager, Luis Aguilera, speaks about the company’s long family history and growth…
Interview: Maurizio Reginato, Commercial Director, Biosano, Chile
“A company active in the Chilean pharmaceutical market has to reinvent its business model every three years…
Interview: Antonio Avila Nieves, General Manager, Tecnofarma, Chile
When Antonio Avila came to Chile in 2011, one of his main goals was to adapt the business model to the current…
The M&A wave has arrived in Chile
The global pharmaceutical sector continues to witness significant mergers and acquisitions activity, with 122…
Interview: Gerardo Sanchez, General Manager, Nutrapharm, Chile
Chile witnessed increasing demand for vitamin and dietary supplements as a result of improvement of disposable…
Interview: Eduardo Loyola, General Manager, Heel, Chile
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at…
